Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001279
Chunk: 13

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 13
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  June 30,  December 31,   2024  2023        ASSETS      Current Assets      Cash $926  $376 Prepaid expenses  -   1,250 Total Current Assets  926   1,626          Operating lease right of use asset  39,755   52,233 Security deposit  4,600   4,600 TOTAL ASSETS $45,281  $58,459          LIABILITIES AND STOCKHOLDERS' DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $152,736  $154,444 Deferred revenue  20,000   20,000 Due to related parties  109,188   88,796 Operating lease liabilities - current  26,105   25,335 Total Current Liabilities  308,029   288,575          Operating lease liabilities - noncurrent  13,650   26,898 TOTAL LIABILITIES  321,679   315,473          Stockholders' Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding as of June 30, 2024 and December 31, 2023  60,042   60,042 Additional paid-in capital  32,300,453   32,298,442 Accumulated deficit  (32,636,893)  (32,615,498)Total Stockholders’ Deficit  (276,398)  (257,014)         TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $45,281  $58,459 

The accompanying notes are an integral part of these unaudited financial statements.

 4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

(Unaudited)

  Three Months Ended   Six Months Ended   June 30,  June 30,   2024